Aves RIP1 through apoptosis of Ba/F3 cells induced by development element withdrawal. Cell Res 2010, 20:421?33. Okada M, Adachi S, Imai T, Watanabe K, Toyokuni SY, Ueno M, Zervos AS, Kroemer G, Nakahata T: A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 2004, 103:2299?307. McCormick AL, Roback L, Mocarski ES: HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog 2008, 4:e1000063. Meyer-Schwesinger C, Meyer TN, M ster S, Klug P, Saleem M, Helmchen U, Stahl RAK: A brand new function for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte procedure formation and podocyte injury in human glomerulopathies. J Pathol 2009, 217:452?64. Boudreaux DA, Maiti TK, Davies CW, Das C: Ubiquitin vinyl methyl ester binding orients the misaligned active website on the ubiquitin hydrolase UCHL1 into productive conformation. Proc Natl Acad Sci USA 2010, 107:9117?122.30. Meyer-Schwesinger C, Meyer TN, Sievert H, Hoxha E, Sachs M, Klupp EM, M ster S, Balabanov S, Carrier L, Helmchen U, et al: Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am J Pathol 2011, 178:2044?057. 31. Zhang H, Sun Y, Hu R, Luo W, Mao X, Zhao Z, Chen Q, Zhang Z: The regulation in the UCH-L1 gene by transcription factor NF-kappaB in podocytes. Cell Signal 2013, 25:1574?585. 32. Cartier AE, Djakovic SN, Salehi A, Wilson SM, Masliah E, Patrick GN: Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. J Neurosci 2009, 29:7857?868. 33. Thon L, Mathieu S, Kabelitz D, Adam D: The murine TRAIL receptor signals caspase-independent cell death via ceramide. Exp Cell Res 2006, 312:3808?821. 34. He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X: Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100?111. 35. Egger L, Madden DT, Rh e C, Rao RV, Bredesen DE: Endoplasmic reticulum stress-induced cell death mediated by the proteasome. Cell Death Differ 2007, 14:1172?180. 36. Cilenti L, Lee Y, Hess S, Srinivasula S, Park KM, Junqueira D, Davis H, Bonventre JV, Alnemri ES, Zervos AS: Characterization of a novel and distinct inhibitor for the pro-apoptotic protease Omi/HtrA2.1699751-03-5 Data Sheet J Biol Chem 2003, 278:11489?1494.N-Fmoc-N-(2-phenylethyl)-glycine Purity 37.PMID:23773119 Chan FKM, Shisler J, Bixby JG, Felices M, Zheng L, Appel M, Orenstein J, Moss B, Lenardo MJ: A part for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 2003, 278:51613?1621. 38. Park DW, Nam MK, Rhim H: The serine protease HtrA2 cleaves UCH-L1 and inhibits its hydrolase activity: implication in the UCH-L1-mediated cell death. Biochem Biophys Res Commun 2011, 415:24?9. 39. Meray RK, Lansbury PT Jr: Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J Biol Chem 2007, 282:10567?0575. 40. Liu Y, Lashuel HA, Choi S, Xing X, Case A, Ni J, Yeh LA, Cuny GD, Stein RL, Lansbury PT Jr: Discovery of inhibitors that elucidate the role of UCH-L1 activity inside the H1299 lung cancer cell line. Chem Biol 2003, ten:837?46. 41. Tharaux PL, Huber TB: How numerous techniques can a podocyte die? Semin Nephrol 2012, 32:394?04. 42. Linkermann A, Br en JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S.
